These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4557278)

  • 41. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR; Loeb V; Dorfman R; Chan YK
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of cytostatic polychemotherapy in non-Hodgkin lymphomas].
    Kratzer H; Hehenwarter W; Denz H; Bliem J; Tschurtschenthaler G; Nitsche D; Huber H; Michlmayr G
    Wien Klin Wochenschr; 1983 Aug; 95(16):558-62. PubMed ID: 6689099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Management of lymphoma with respect to pathologic classification: updates and controversies].
    Zhu J; Song YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
    [No Abstract]   [Full Text] [Related]  

  • 46. [Combination chemotherapy with methotrexate, endoxan, and vincristine (M.E.V.) in the treatment of non-Hodgkin's lymphoma (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Tura S
    Tumori; 1973; 59(6):401-8. PubMed ID: 4598587
    [No Abstract]   [Full Text] [Related]  

  • 47. Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
    Al-Katib AM; Aboukameel A; Mohammad R; Bissery MC; Zuany-Amorim C
    Clin Cancer Res; 2009 Jun; 15(12):4038-45. PubMed ID: 19509168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
    Klener P; Donner L
    Acta Haematol; 1977; 57(5):272-8. PubMed ID: 66832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy of malignant non-Hodgkin's lymphoma].
    Jandl H; Fuchs R
    Z Gesamte Inn Med; 1979 Apr; 34(7):208-12. PubMed ID: 582641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined modality treatment in stage I and II diffuse non-Hodgkin's lymphomas.
    Bonadonna G; Valagussa P; Buzzoni R; Bajetta E
    Prog Clin Biol Res; 1985; 201():369-74. PubMed ID: 2419921
    [No Abstract]   [Full Text] [Related]  

  • 55. The need of adequate staging and aggressive therapy in non-Hodgkin's lymphomas. Report of 66 cases.
    Johansson RT; Joensuu H
    Strahlentherapie; 1983 Feb; 159(2):104-8. PubMed ID: 6836627
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapy of non-Hodgkin's lymphomas in relapse.
    Klener P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):36-40. PubMed ID: 6157622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
    Cavallin-Ståhl E; Möller TR
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The indication for chemotherapy in the lymphomas.
    Rosenberg SA
    Proc Natl Cancer Conf; 1970; 6():83-9. PubMed ID: 5458149
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
    Case DC
    J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
    [No Abstract]   [Full Text] [Related]  

  • 60. The non-Hodgkin's lymphomas: a review.
    Golomb HM; Moran EM; Ultmann JE
    Rev Bras Pesqui Med Biol; 1974; 7(2):123-31. PubMed ID: 4605305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.